VKH
TEVA icon

Virtu KCG Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Virtu KCG Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-55,676
Closed -$1.79M – 3486
2017
Q1 		$1.79M Sell
55,676
-11,569
-17% -$395K 0.05% 315
2016
Q4 		$2.44M Sell
67,245
-110,049
-62% -$4.39M 0.06% 231
2016
Q3 		$8.16M Buy
177,294
+96,850
+120% +$5.05M 0.19% 40
2016
Q2 		$4.04M Buy
80,444
+2,029
+3% +$108K 0.08% 122
2016
Q1 		$4.2M Buy
78,415
+72,295
+1,181% +$4.24M 0.12% 86
2015
Q4 		$402K Sell
6,120
-97,585
-94% -$6.03M 0.01% 1801
2015
Q3 		$5.86M Buy
103,705
+96,005
+1,247% +$6.22M 0.1% 117
2015
Q2 		$455K Sell
7,700
-1,927
-20% -$119K 0.01% 1578
2015
Q1 		$600K Buy
+9,627
New +$560K 0.01% 1195
2014
Q4 		– Sell
-9,954
Closed -$555K – 4226
2014
Q3 		$535K Sell
9,954
-29,580
-75% -$1.57M 0.01% 1625
2014
Q2 		$2.07M Buy
39,534
+22,357
+130% +$1.14M 0.03% 517
2014
Q1 		$908K Sell
17,177
-17,399
-50% -$804K 0.01% 1324
2013
Q4 		$1.39M Buy
34,576
+16,140
+88% +$636K 0.02% 924
2013
Q3 		$697K Buy
+18,436
New +$719K 0.01% 1598

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Virtu KCG Holdings's TEVA Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 55,676 shares — an estimated $1.79M sold.

Virtu KCG Holdings first reported a position in TEVA in Q3 2013 and held it in 14 quarters. The position peaked at $8.16M in Q3 2016. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 55,676 Teva Pharmaceuticals shares in Q2 2017, an estimated $1.79M.
  • Virtu KCG Holdings first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 14 quarters.
  • Virtu KCG Holdings's Teva Pharmaceuticals position peaked at $8.16M in Q3 2016.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.